Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Petracca

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
European Radiology|February 27, 2020
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosisGiuseppe Pontillo, Sirio Cocozza, Martina Di Stasi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 28, 2017
Cerebellar lobule atrophy and disability in progressive MSSirio Cocozza, Maria Petracca, Enricomaria Mormina, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 7, 2015
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania regionChiara de Waure, Francesco Di Nardo, Walter Mazzucco, et al.
Journal of Clinical Medicine|April 3, 2021
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 OutbreakAntonio Carotenuto, Cristiano Scandurra, Teresa Costabile, et al.
Neurology and Therapy|June 2, 2022
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up StudyMaria Petracca, Serena Ruggieri, Elena Barbuti, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 12, 2021
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison StudyAurora Zanghì, Antonio Gallo, Carlo Avolio, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 27, 2024
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experienceSerena Ruggieri, Antonio Ianniello, Massimiliano Copetti, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 22, 2023
Using The Virtual Brain to study the relationship between structural and functional connectivity in patients with multiple sclerosis: a multicenter studyGerard Martí-Juan, Jaume Sastre-Garriga, Eloy Martinez-Heras, et al.
Network Neuroscience (Cambridge, Mass.)|December 30, 2024
Conservation of structural brain connectivity in people with multiple sclerosisGerard Martí-Juan, Jaume Sastre-Garriga, Angela Vidal-Jordana, et al.
Journal of Clinical Medicine|April 23, 2022
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter StudyRoberta Lanzillo, Antonio Carotenuto, Elisabetta Signoriello, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
European Radiology|February 27, 2020
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosisGiuseppe Pontillo, Sirio Cocozza, Martina Di Stasi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 28, 2017
Cerebellar lobule atrophy and disability in progressive MSSirio Cocozza, Maria Petracca, Enricomaria Mormina, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 7, 2015
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania regionChiara de Waure, Francesco Di Nardo, Walter Mazzucco, et al.
Journal of Clinical Medicine|April 3, 2021
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 OutbreakAntonio Carotenuto, Cristiano Scandurra, Teresa Costabile, et al.
Neurology and Therapy|June 2, 2022
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up StudyMaria Petracca, Serena Ruggieri, Elena Barbuti, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 12, 2021
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison StudyAurora Zanghì, Antonio Gallo, Carlo Avolio, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 27, 2024
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experienceSerena Ruggieri, Antonio Ianniello, Massimiliano Copetti, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 22, 2023
Using The Virtual Brain to study the relationship between structural and functional connectivity in patients with multiple sclerosis: a multicenter studyGerard Martí-Juan, Jaume Sastre-Garriga, Eloy Martinez-Heras, et al.
Network Neuroscience (Cambridge, Mass.)|December 30, 2024
Conservation of structural brain connectivity in people with multiple sclerosisGerard Martí-Juan, Jaume Sastre-Garriga, Angela Vidal-Jordana, et al.
Journal of Clinical Medicine|April 23, 2022
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter StudyRoberta Lanzillo, Antonio Carotenuto, Elisabetta Signoriello, et al.
Pageof 14